China SXT Pharmaceuticals (SXTC) Construction in Progress (2018 - 2023)
China SXT Pharmaceuticals' Construction in Progress came in at $349,390 for fiscal Q4 2023 (quarter ended Mar 31, 2023), down 3.8% from $363,078 a year earlier.
Powered by 
Analysis
China SXT Pharmaceuticals (SXTC) Construction in Progress (2018 - 2023) Analysis & Trends
Going back to fiscal Q4 2018, China SXT Pharmaceuticals' Construction in Progress data covers 11 quarters.
- Construction in Progress carries a five-year compound annual growth rate of -11.0% (FY2018 to FY2023).
- Going back by fiscal year, Construction in Progress was $363,078 in FY2022 (+2.1%), $355,614 in FY2021 (+8.3%), $328,372 in FY2020 (-49.4%) and $649,235 in FY2019 (+3.6%).
- The five-year range for quarterly Construction in Progress is $180,000 (fiscal Q2 2020) to $649,235 (fiscal Q4 2019).
- Year-over-year, Construction in Progress increased in 1 of the last four quarters, with an average decline of 6.5%.
- The fastest year-over-year change in Construction in Progress over five years came in fiscal Q2 2021 (growth of 149.7%), and the weakest in fiscal Q2 2020 (a decline of 68.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | China SXT Pharmaceuticals | 33,069.96 | -85.92 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 349,390.00 |
| Sep 30, 2022 | 343,153.00 |
| Mar 31, 2022 | 363,078.00 |
| Sep 30, 2021 | 358,569.00 |
| Mar 31, 2021 | 355,614.00 |
| Sep 30, 2020 | 449,464.00 |
| Mar 31, 2020 | 328,372.00 |
| Sep 30, 2019 | 180,000.00 |
| Mar 31, 2019 | 649,235.00 |
| Sep 30, 2018 | 572,811.00 |
| Mar 31, 2018 | 626,404.00 |
API Access
China SXT Pharmaceuticals Construction in Progress API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=construction-in-progress&ticker=SXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "construction-in-progress", "ticker": "SXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=construction-in-progress&ticker=SXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();